首页 | 本学科首页   官方微博 | 高级检索  
     

PET/MRI在高级别脑胶质瘤放射治疗中的应用
引用本文:赵永瑞,徐建堃 审校. PET/MRI在高级别脑胶质瘤放射治疗中的应用[J]. 实用肿瘤学杂志, 2017, 31(6): 564-568. DOI: 10.11904/j.issn.1002-3070.2017.06.016
作者姓名:赵永瑞  徐建堃 审校
作者单位:首都医科大学宣武医院(北京 100053)
摘    要:
脑胶质瘤是最常见的原发性神经系统肿瘤,其中高级别胶质瘤生长迅速,常呈浸润性生长,且治疗后易复发,死亡率和致残率都很高。手术切除仍是高级别胶质瘤的首选治疗方法,术后放射治疗则是其重要的辅助治疗手段之一。目前放射治疗多以MRI图像指导靶区的勾画,但MRI在肿瘤显像方面仍存在局限性。随着多种放射性示踪剂的研究及应用,PET能够通过肿瘤组织的代谢变化来反映肿瘤的浸润范围,还有助于鉴别放射性坏死与肿瘤复发。PET/MRI的联合应用在高级别脑胶质瘤的放射治疗中具有很好的应用前景。

关 键 词:高级别脑胶质瘤  正电子发射断层显像术  磁共振显像  放射治疗  
收稿时间:2017-01-17

The application of PET/MRI in high-grade glioma by radiotherapy
ZHAO Yongrui,XU Jiankun. The application of PET/MRI in high-grade glioma by radiotherapy[J]. Journal of Practical Oncology, 2017, 31(6): 564-568. DOI: 10.11904/j.issn.1002-3070.2017.06.016
Authors:ZHAO Yongrui  XU Jiankun
Affiliation:Department of Radiation Oncology,Xuanwu Hospital,Capital Medical University,Beijing 100053,China
Abstract:
Regulation of calcineurin 1(RCAN1),as an endogenous protein that interacts with calcineurin(CaN),widely expresses in many malignant tumor cells,such as small cell lung cancer,thyroid cancer,leukemia,liver cancer,malignant glioma,endometrial adenocarcinoma and so on.In recent years,many studies have been shown that when RCAN1 is highly expressed,it can inhibit tumor proliferation,differentiation,invasion and metastasis by a variety of ways,thereby inhibiting tumor progression.These findings play an important role in the survival and prognosis of patients,and provide a theoretical basis for the treatment and intervention of malignant tumors.
Keywords:High-grade glioma  Positron emission tomography  Magnetic resonance imaging  Radiotherapy  
点击此处可从《实用肿瘤学杂志》浏览原始摘要信息
点击此处可从《实用肿瘤学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号